HIGH-RISK CANCER
Clinical trials for HIGH-RISK CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK CANCER trials appear
Sign up with your email to follow new studies for HIGH-RISK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail approach aims to wipe out High-Risk rectal cancer without surgery
Disease control CompletedThis phase 2 trial tests a powerful mix of short-course radiation, chemotherapy (mFOLFOX6), an immunotherapy (PD-1 antibody), and a targeted drug (cetuximab or bevacizumab, depending on genetic markers) in people with high-risk rectal cancer that is mismatch repair proficient (pM…
Matched conditions: HIGH-RISK CANCER
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New study explores what matters most to patients with high-risk head and neck skin cancer
Knowledge-focused CompletedThis study looked at how 78 patients with high-risk skin cancer on the head or neck felt about their treatment decisions, quality of life, and satisfaction with care. Researchers used standard questionnaires to measure these factors at two points: right after a team of doctors di…
Matched conditions: HIGH-RISK CANCER
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC